1 2657 296 YOGA IN ADDITION TO STANDARD CARE FOR PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES. BACKGROUND: HAEMATOLOGICAL MALIGNANCIES ARE MALIGNANT NEOPLASMS OF THE MYELOID OR LYMPHATIC CELL LINES INCLUDING LEUKAEMIA, LYMPHOMA AND MYELOMA. IN ORDER TO MANAGE PHYSICAL AND PSYCHOLOGICAL ASPECTS OF THE DISEASE AND ITS TREATMENT, COMPLEMENTARY THERAPIES LIKE YOGA ARE COMING INCREASINGLY INTO FOCUS. HOWEVER, THE EFFECTIVENESS OF YOGA PRACTICE FOR PEOPLE SUFFERING FROM HAEMATOLOGICAL MALIGNANCIES REMAINS UNCLEAR. OBJECTIVES: TO ASSESS THE EFFECTS OF YOGA PRACTICE IN ADDITION TO STANDARD CANCER TREATMENT FOR PEOPLE WITH HAEMATOLOGICAL MALIGNANCIES. SEARCH METHODS: OUR SEARCH STRATEGY INCLUDED THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS (CENTRAL), MEDLINE (1950 TO 4TH FEBRUARY 2014), DATABASES OF ONGOING TRIALS (CONTROLLED-TRIALS.COM; CLINICALTRIALS.GOV), CONFERENCE PROCEEDINGS OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, THE AMERICAN SOCIETY OF HEMATOLOGY, THE EUROPEAN HAEMATOLOGY ASSOCIATION, THE EUROPEAN CONGRESS FOR INTEGRATIVE MEDICINE, AND GLOBAL ADVANCES IN HEALTH AND MEDICINE. WE HANDSEARCHED REFERENCES OF THESE STUDIES FROM IDENTIFIED TRIALS AND RELEVANT REVIEW ARTICLES. TWO REVIEW AUTHORS INDEPENDENTLY SCREENED THE SEARCH RESULTS. SELECTION CRITERIA: WE INCLUDED RANDOMISED CONTROLLED TRIALS (RCTS) OF YOGA IN ADDITION TO STANDARD CARE FOR HAEMATOLOGICAL MALIGNANCIES COMPARED WITH STANDARD CARE ONLY. WE DID NOT RESTRICT THIS TO ANY SPECIFIC STYLE OF YOGA. DATA COLLECTION AND ANALYSIS: TWO REVIEW AUTHORS INDEPENDENTLY EXTRACTED DATA FOR ELIGIBLE STUDIES AND ASSESSED THE RISK OF BIAS ACCORDING TO PREDEFINED CRITERIA. WE EVALUATED DISTRESS, FATIGUE, ANXIETY, DEPRESSION AND QUALITY OF SLEEP. FURTHER OUTCOMES WE PLANNED TO ASSESS WERE HEALTH-RELATED QUALITY OF LIFE (HRQOL), OVERALL SURVIVAL (OS) AND ADVERSE EVENTS (AE), BUT DATA ON THESE WERE NOT AVAILABLE. MAIN RESULTS: OUR SEARCH STRATEGIES LED TO 149 POTENTIALLY RELEVANT REFERENCES, BUT ONLY A SINGLE SMALL STUDY MET OUR INCLUSION CRITERIA. THE INCLUDED STUDY WAS PUBLISHED AS A FULL TEXT ARTICLE AND INVESTIGATED THE FEASIBILITY AND EFFECT OF TIBETAN YOGA ADDITIONAL TO STANDARD CARE (N = 20; 1 PERSON DROPPED OUT BEFORE ATTENDING ANY CLASSES AND NO DATA WERE COLLECTED) COMPARED TO STANDARD CARE ONLY (N = 19). THE STUDY INCLUDED PEOPLE WITH ALL STAGES OF HODGKIN AND NON-HODGKIN'S LYMPHOMA, WITH AND WITHOUT CURRENT CANCER TREATMENT. THE MEAN AGE WAS 51 YEARS.WE JUDGED THE OVERALL RISK OF BIAS AS HIGH AS WE FOUND A HIGH RISK FOR PERFORMANCE, DETECTION AND ATTRITION BIAS. ADDITIONALLY, POTENTIAL OUTCOME REPORTING BIAS COULD NOT BE COMPLETELY RULED OUT. FOLLOWING THE RECOMMENDATIONS OF GRADE, WE JUDGED THE OVERALL QUALITY OF THE BODY OF EVIDENCE FOR ALL PREDEFINED OUTCOMES AS 'VERY LOW', DUE TO THE METHODICAL LIMITATIONS AND THE VERY SMALL SAMPLE SIZE.THE INFLUENCE OF YOGA ON HRQOL AND OS WAS NOT REPORTED. THERE IS NO EVIDENCE THAT YOGA IN ADDITION TO STANDARD CARE COMPARED WITH STANDARD CARE ONLY CAN IMPROVE DISTRESS IN PEOPLE WITH HAEMATOLOGICAL MALIGNANCIES (MEAN DIFFERENCE (MD) -0.30, 95% CONFIDENCE INTERVAL (CI) -5.55 TO 4.95; P = 0.91). SIMILARLY, THERE IS NO EVIDENCE OF A DIFFERENCE BETWEEN EITHER GROUP FOR FATIGUE (MD 0.00, 95% CI -0.94 TO 0.94; P = 1.00), ANXIETY (MD 0.30, 95% CI -5.01 TO 5.61; P = 0.91) OR DEPRESSION (MD -0.70, 95% CI -3.21 TO 1.81; P = 0.58).THERE IS VERY LOW QUALITY EVIDENCE THAT YOGA IMPROVES THE OVERALL QUALITY OF SLEEP (MD -2.30, 95% CI -3.78 TO -0.82; P = 0.002). THE YOGA GROUPS' TOTAL SCORE FOR THE PITTSBURGH SLEEP QUALITY INDEX (PSQI) WAS 5.8 (+/- 2.3 SD) AND BETTER THAN THE TOTAL SCORE (8.1 (+/- 2.4 SD)) OF THE CONTROL GROUP. A PSQI TOTAL SCORE OF 0 TO 5 INDICATES GOOD SLEEP WHEREAS PSQI TOTAL SCORE 6 TO 21 POINTS TOWARDS SIGNIFICANT SLEEP DISTURBANCES. THE OCCURRENCE OF AES WAS NOT REPORTED. AUTHORS' CONCLUSIONS: THE CURRENTLY AVAILABLE DATA PROVIDE LITTLE INFORMATION ABOUT THE EFFECTIVENESS OF YOGA INTERVENTIONS FOR PEOPLE SUFFERING FROM HAEMATOLOGICAL MALIGNANCIES. THE FINDING THAT YOGA MAY BE BENEFICIAL FOR THE PATIENTS' QUALITY OF SLEEP IS BASED ON A VERY SMALL BODY OF EVIDENCE. THEREFORE, THE ROLE OF YOGA AS AN ADDITIONAL THERAPY FOR HAEMATOLOGICAL MALIGNANCIES REMAINS UNCLEAR. FURTHER HIGH-QUALITY RANDOMISED CONTROLLED TRIALS WITH LARGER NUMBERS OF PARTICIPANTS ARE NEEDED TO MAKE A DEFINITIVE STATEMENT. 2014 2 2198 67 THE EFFICACY OF BODY-ORIENTED YOGA IN MENTAL DISORDERS-A SYSTEMATIC REVIEW AND META-ANALYSIS BACKGROUND: THE EFFICACY OF BODY-ORIENTED YOGA IN THE TREATMENT OF MENTAL DISORDERS HAS BEEN INVESTIGATED IN NUMEROUS STUDIES. THIS ARTICLE IS A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE RELEVANT PUBLICATIONS. METHODS: ALL STUDIES IN WHICH THE EFFICACY OF HATHA-YOGA, I.E., BODY-ORIENTED YOGA WITH ASANAS AND PRANAYAMA, WAS STUDIED IN ADULT PATIENTS SUFFERING FROM A MENTAL DISORDER (AS DIAGNOSED BY ICD OR DSM CRITERIA) WERE INCLUDED IN THE ANALYSIS. THE PRIMARY ENDPOINT WAS DISORDER-SPECIFIC SYMPTOM SEVERITY. THE PUBLICATIONS WERE IDENTIFIED BY A SYSTEMATIC SEARCH IN THE PUBMED, WEB OF SCIENCE, PSYCINFO AND PROQUEST DATABASES, SUPPLEMENTED BY A SEARCH WITH THE GOOGLE SCHOLAR SEARCH ENGINE AND A MANUAL SEARCH IN THE REFERENCE LISTS OF META-ANALYSES AND PRIMARY STUDIES, AS WELL AS IN SPECIALIZED JOURNALS. RESULTS: 25 STUDIES WITH A TOTAL OF 1339 PATIENTS WERE INCLUDED IN THE ANALYSIS. A LARGE AND SIGNIFICANT EFFECT OF YOGA WAS SEEN WITH RESPECT TO THE PRIMARY ENDPOINT (SYMPTOM SEVERITY) (HEDGES' G = 0.91; 95% CONFIDENCE INTERVAL [0.55; 1.28]; NUMBER NEEDED TO TREAT [NNT]: 2.03), WITH SUBSTANTIAL HETEROGENEITY (I2 = 69.8%) COMPARED TO UNTREATED CONTROL GROUPS. SMALL BUT SIGNIFICANT EFFECTS OF YOGA WERE ALSO SEEN IN COMPARISON WITH ATTENTION CONTROL (G = 0.39; [0.04; 0.73]; NNT: 4.55) AND PHYSICAL EXERCISE (G = 0.30; [0.01; 0.59]; NNT: 5.75); NO DIFFERENCE IN EFFICACY WAS FOUND BETWEEN YOGA AND STANDARD PSYCHOTHERAPY (G = 0.08; [-0.24; 0,40]; NNT: 21.89). IN VIEW OF THE RELATIVELY HIGH RISK OF BIAS, THESE FINDINGS SHOULD BE INTERPRETED WITH CAUTION. CONCLUSION: BODY-ORIENTED YOGA WITH ASANAS AND PRANAYAMA AS CENTRAL COMPONENTS IS A PROMISING COMPLEMENTARY TREATMENT FOR MENTAL DISORDERS AND SHOULD BE INVESTIGATED IN FURTHER HIGH-QUALITY STUDIES. 2016 3 1035 50 EFFECTS OF YOGA IN INFLAMMATORY BOWEL DISEASES AND ON FREQUENT IBD-ASSOCIATED EXTRAINTESTINAL SYMPTOMS LIKE FATIGUE AND DEPRESSION. QUALITY OF LIFE (QOL) OF PERSONS WITH INFLAMMATORY BOWEL DISEASES (IBD) IS OFTEN IMPAIRED BY SYMPTOMS THAT DO NOT PRIMARILY RELATE TO INTESTINAL INFLAMMATION. AMONG THE MOST CHALLENGING EXTRAINTESTINAL SYMPTOMS ARE DEPRESSION AND FATIGUE, WHICH ARE ALSO FREQUENT IN OTHER CHRONIC DISEASES LIKE MULTIPLE SCLEROSIS, RHEUMATOID ARTHRITIS AND CANCER. YOGA AS AN ANCIENT INDIAN TRADITION CONTAINING POSTURES, BREATHING EXERCISES AND MEDITATION MAY POSITIVELY INFLUENCE THOSE SYMPTOMS. THIS REVIEW EVALUATES THE CURRENT LITERATURE WITH REGARD TO THE EFFECT OF YOGA-BASED INTERVENTIONS IN PERSONS WITH IBD AND WITH REGARD TO QOL, DEPRESSION AND FATIGUE IN OTHER SOMATIC DISORDERS. A SYSTEMATIC LITERATURE SEARCH YIELDED THREE TRIALS EXAMINING THE EFFECTS OF YOGA IN PATIENTS WITH IBD AND 37 TRIALS ADDRESSING DEPRESSIVE SYNDROMES OR FATIGUE IN SOMATIC DISORDERS. IN SUMMARY, BOTH IN-PERSON AND VIDEO-BASED YOGA CLASSES ARE FEASIBLE, ACCEPTABLE AND SAFE AS COMPLEMENTARY TREATMENT IN PATIENTS WITH IBD AND SIGNIFICANTLY IMPROVE ANXIETY AND IMPAIRED QUALITY OF LIFE. CURRENT LITERATURE DOES NOT PROVIDE INFORMATION ON THE EFFECT OF YOGA ON DEPRESSION AND FATIGUE IN PATIENTS WITH IBD, BUT RESEARCH FROM OTHER SOMATIC DISORDERS OR PATIENTS WITH DEPRESSIVE DISORDERS IMPLIES THE POTENTIAL OF YOGA IN THIS REGARD FOR PERSONS WITH IBD. THIS SHOULD BE SPECIFICALLY ADDRESSED IN INTERVENTIONAL TRIALS WITH STANDARDIZED YOGA MODULES INCLUDING PATIENTS WITH IBD SUFFERING FROM FATIGUE, DEPRESSION AND/OR IMPAIRED QOL. 2021 4 931 88 EFFECTIVENESS OF YOGA THERAPY AS A COMPLEMENTARY TREATMENT FOR MAJOR PSYCHIATRIC DISORDERS: A META-ANALYSIS. OBJECTIVE: TO EXAMINE THE EFFICACY OF YOGA THERAPY AS A COMPLEMENTARY TREATMENT FOR PSYCHIATRIC DISORDERS SUCH AS SCHIZOPHRENIA, DEPRESSION, ANXIETY, AND POSTTRAUMATIC STRESS DISORDER (PTSD). DATA SOURCES: ELIGIBLE TRIALS WERE IDENTIFIED BY A LITERATURE SEARCH OF PUBMED/MEDLINE, COCHRANE CONTROL TRIALS REGISTER, GOOGLE SCHOLAR, AND EBSCO ON THE BASIS OF CRITERIA OF ACCEPTABLE QUALITY AND RELEVANCE. THE SEARCH WAS PERFORMED USING THE FOLLOWING TERMS: YOGA FOR SCHIZOPHRENIA, YOGA FOR DEPRESSION, YOGA FOR ANXIETY, YOGA FOR PTSD, YOGA THERAPY, YOGA FOR PSYCHIATRIC DISORDERS, COMPLEMENTARY TREATMENT, AND EFFICACY OF YOGA THERAPY. TRIALS BOTH UNPUBLISHED AND PUBLISHED WITH NO LIMITATION PLACED ON YEAR OF PUBLICATION WERE INCLUDED; HOWEVER, THE OLDEST ARTICLE INCLUDED IN THE FINAL META-ANALYSIS WAS PUBLISHED IN 2000. STUDY SELECTION: ALL AVAILABLE RANDOMIZED, CONTROLLED TRIALS OF YOGA FOR THE TREATMENT OF MENTAL ILLNESS WERE REVIEWED, AND 10 STUDIES WERE ELIGIBLE FOR INCLUSION. AS VERY FEW RANDOMIZED, CONTROLLED STUDIES HAVE EXAMINED YOGA FOR MENTAL ILLNESS, THIS META-ANALYSIS INCLUDES STUDIES WITH PARTICIPANTS WHO WERE DIAGNOSED WITH MENTAL ILLNESS, AS WELL AS STUDIES WITH PARTICIPANTS WHO WERE NOT DIAGNOSED WITH MENTAL ILLNESS BUT REPORTED SYMPTOMS OF MENTAL ILLNESS. TRIALS WERE EXCLUDED DUE TO THE FOLLOWING: (1) INSUFFICIENT INFORMATION, (2) INADEQUATE STATISTICAL ANALYSIS, (3) YOGA WAS NOT THE CENTRAL COMPONENT OF THE INTERVENTION, (4) SUBJECTS WERE NOT DIAGNOSED WITH OR DID NOT REPORT EXPERIENCING SYMPTOMS OF ONE OF THE PSYCHIATRIC DISORDERS OF INTEREST (IE, SCHIZOPHRENIA, DEPRESSION, ANXIETY, AND PTSD), (5) STUDY WAS NOT REPORTED IN ENGLISH, AND (6) STUDY DID NOT INCLUDE A CONTROL GROUP. DATA EXTRACTION: DATA WERE EXTRACTED ON PARTICIPANT DIAGNOSIS, INCLUSION CRITERIA, TREATMENT AND CONTROL GROUPS, DURATION OF INTERVENTION, AND RESULTS (PRE-POST MEAN AND STANDARD DEVIATIONS, T VALUES, AND F VALUES). NUMBER, AGE, AND SEX RATIO OF PARTICIPANTS WERE ALSO OBTAINED WHEN AVAILABLE. DATA SYNTHESIS: THE COMBINED ANALYSIS OF ALL 10 STUDIES PROVIDED A POOLED EFFECT SIZE OF -3.25 (95% CI, -5.36 TO -1.14; P = .002), INDICATING THAT YOGA-BASED INTERVENTIONS HAVE A STATISTICALLY SIGNIFICANT EFFECT AS AN ADJUNCT TREATMENT FOR MAJOR PSYCHIATRIC DISORDERS. FINDINGS IN SUPPORT OF ALTERNATIVE AND COMPLEMENTARY INTERVENTIONS MAY ESPECIALLY BE AN AID IN THE TREATMENT OF DISORDERS FOR WHICH CURRENT TREATMENTS ARE FOUND TO BE INADEQUATE OR TO CARRY SEVERE LIABILITIES. CONCLUSIONS: AS CURRENT PSYCHOPHARMACOLOGIC INTERVENTIONS FOR SEVERE MENTAL ILLNESS ARE ASSOCIATED WITH INCREASED RISK OF WEIGHT GAIN AS WELL AS OTHER METABOLIC SIDE EFFECTS THAT INCREASE PATIENTS' RISK FOR CARDIOVASCULAR DISEASE, YOGA MAY BE AN EFFECTIVE, FAR LESS TOXIC ADJUNCT TREATMENT OPTION FOR SEVERE MENTAL ILLNESS. 2011 5 2543 128 YOGA FOR ASTHMA. BACKGROUND: ASTHMA IS A COMMON CHRONIC INFLAMMATORY DISORDER AFFECTING ABOUT 300 MILLION PEOPLE WORLDWIDE. AS A HOLISTIC THERAPY, YOGA HAS THE POTENTIAL TO RELIEVE BOTH THE PHYSICAL AND PSYCHOLOGICAL SUFFERING OF PEOPLE WITH ASTHMA, AND ITS POPULARITY HAS EXPANDED GLOBALLY. A NUMBER OF CLINICAL TRIALS HAVE BEEN CARRIED OUT TO EVALUATE THE EFFECTS OF YOGA PRACTICE, WITH INCONSISTENT RESULTS. OBJECTIVES: TO ASSESS THE EFFECTS OF YOGA IN PEOPLE WITH ASTHMA. SEARCH METHODS: WE SYSTEMATICALLY SEARCHED THE COCHRANE AIRWAYS GROUP REGISTER OF TRIALS, WHICH IS DERIVED FROM SYSTEMATIC SEARCHES OF BIBLIOGRAPHIC DATABASES INCLUDING THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS (CENTRAL), MEDLINE, EMBASE, CINAHL, AMED, AND PSYCINFO, AND HANDSEARCHING OF RESPIRATORY JOURNALS AND MEETING ABSTRACTS. WE ALSO SEARCHED PEDRO. WE SEARCHED CLINICALTRIALS.GOV AND THE WHO ICTRP SEARCH PORTAL. WE SEARCHED ALL DATABASES FROM THEIR INCEPTION TO 22 JULY 2015, AND USED NO RESTRICTION ON LANGUAGE OF PUBLICATION. WE CHECKED THE REFERENCE LISTS OF ELIGIBLE STUDIES AND RELEVANT REVIEW ARTICLES FOR ADDITIONAL STUDIES. WE ATTEMPTED TO CONTACT INVESTIGATORS OF ELIGIBLE STUDIES AND EXPERTS IN THE FIELD TO LEARN OF OTHER PUBLISHED AND UNPUBLISHED STUDIES. SELECTION CRITERIA: WE INCLUDED RANDOMISED CONTROLLED TRIALS (RCTS) THAT COMPARED YOGA WITH USUAL CARE (OR NO INTERVENTION) OR SHAM INTERVENTION IN PEOPLE WITH ASTHMA AND REPORTED AT LEAST ONE OF THE FOLLOWING OUTCOMES: QUALITY OF LIFE, ASTHMA SYMPTOM SCORE, ASTHMA CONTROL, LUNG FUNCTION MEASURES, ASTHMA MEDICATION USAGE, AND ADVERSE EVENTS. DATA COLLECTION AND ANALYSIS: WE EXTRACTED BIBLIOGRAPHIC INFORMATION, CHARACTERISTICS OF PARTICIPANTS, CHARACTERISTICS OF INTERVENTIONS AND CONTROLS, CHARACTERISTICS OF METHODOLOGY, AND RESULTS FOR THE OUTCOMES OF OUR INTEREST FROM ELIGIBLE STUDIES. FOR CONTINUOUS OUTCOMES, WE USED MEAN DIFFERENCE (MD) WITH 95% CONFIDENCE INTERVAL (CI) TO DENOTE THE TREATMENT EFFECTS, IF THE OUTCOMES WERE MEASURED BY THE SAME SCALE ACROSS STUDIES. ALTERNATIVELY, IF THE OUTCOMES WERE MEASURED BY DIFFERENT SCALES ACROSS STUDIES, WE USED STANDARDISED MEAN DIFFERENCE (SMD) WITH 95% CI. FOR DICHOTOMOUS OUTCOMES, WE USED RISK RATIO (RR) WITH 95% CI TO MEASURE THE TREATMENT EFFECTS. WE PERFORMED META-ANALYSIS WITH REVIEW MANAGER 5.3. WE USED THE FIXED-EFFECT MODEL TO POOL THE DATA, UNLESS THERE WAS SUBSTANTIAL HETEROGENEITY AMONG STUDIES, IN WHICH CASE WE USED THE RANDOM-EFFECTS MODEL INSTEAD. FOR OUTCOMES INAPPROPRIATE OR IMPOSSIBLE TO POOL QUANTITATIVELY, WE CONDUCTED A DESCRIPTIVE ANALYSIS AND SUMMARISED THE FINDINGS NARRATIVELY. MAIN RESULTS: WE INCLUDED 15 RCTS WITH A TOTAL OF 1048 PARTICIPANTS. MOST OF THE TRIALS WERE CONDUCTED IN INDIA, FOLLOWED BY EUROPE AND THE UNITED STATES. THE MAJORITY OF PARTICIPANTS WERE ADULTS OF BOTH SEXES WITH MILD TO MODERATE ASTHMA FOR SIX MONTHS TO MORE THAN 23 YEARS. FIVE STUDIES INCLUDED YOGA BREATHING ALONE, WHILE THE OTHER STUDIES ASSESSED YOGA INTERVENTIONS THAT INCLUDED BREATHING, POSTURE, AND MEDITATION. INTERVENTIONS LASTED FROM TWO WEEKS TO 54 MONTHS, FOR NO MORE THAN SIX MONTHS IN THE MAJORITY OF STUDIES. THE RISK OF BIAS WAS LOW ACROSS ALL DOMAINS IN ONE STUDY AND UNCLEAR OR HIGH IN AT LEAST ONE DOMAIN FOR THE REMAINDER.THERE WAS SOME EVIDENCE THAT YOGA MAY IMPROVE QUALITY OF LIFE (MD IN ASTHMA QUALITY OF LIFE QUESTIONNAIRE (AQLQ) SCORE PER ITEM 0.57 UNITS ON A 7-POINT SCALE, 95% CI 0.37 TO 0.77; 5 STUDIES; 375 PARTICIPANTS), IMPROVE SYMPTOMS (SMD 0.37, 95% CI 0.09 TO 0.65; 3 STUDIES; 243 PARTICIPANTS), AND REDUCE MEDICATION USAGE (RR 5.35, 95% CI 1.29 TO 22.11; 2 STUDIES) IN PEOPLE WITH ASTHMA. THE MD FOR AQLQ SCORE EXCEEDED THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE (MCID) OF 0.5, BUT WHETHER THE MEAN CHANGES EXCEEDED THE MCID FOR ASTHMA SYMPTOMS IS UNCERTAIN DUE TO THE LACK OF AN ESTABLISHED MCID IN THE SEVERITY SCORES USED IN THE INCLUDED STUDIES. THE EFFECTS OF YOGA ON CHANGE FROM BASELINE FORCED EXPIRATORY VOLUME IN ONE SECOND (MD 0.04 LITRES, 95% CI -0.10 TO 0.19; 7 STUDIES; 340 PARTICIPANTS; I(2) = 68%) WERE NOT STATISTICALLY SIGNIFICANT. TWO STUDIES INDICATED IMPROVED ASTHMA CONTROL, BUT DUE TO VERY SIGNIFICANT HETEROGENEITY (I(2) = 98%) WE DID NOT POOL DATA. NO SERIOUS ADVERSE EVENTS ASSOCIATED WITH YOGA WERE REPORTED, BUT THE DATA ON THIS OUTCOME WAS LIMITED. AUTHORS' CONCLUSIONS: WE FOUND MODERATE-QUALITY EVIDENCE THAT YOGA PROBABLY LEADS TO SMALL IMPROVEMENTS IN QUALITY OF LIFE AND SYMPTOMS IN PEOPLE WITH ASTHMA. THERE IS MORE UNCERTAINTY ABOUT POTENTIAL ADVERSE EFFECTS OF YOGA AND ITS IMPACT ON LUNG FUNCTION AND MEDICATION USAGE. RCTS WITH A LARGE SAMPLE SIZE AND HIGH METHODOLOGICAL AND REPORTING QUALITY ARE NEEDED TO CONFIRM THE EFFECTS OF YOGA FOR ASTHMA. 2016 6 2732 61 YOGA ON OUR MINDS: A SYSTEMATIC REVIEW OF YOGA FOR NEUROPSYCHIATRIC DISORDERS. BACKGROUND: THE DEMAND FOR CLINICALLY EFFICACIOUS, SAFE, PATIENT ACCEPTABLE, AND COST-EFFECTIVE FORMS OF TREATMENT FOR MENTAL ILLNESS IS GROWING. SEVERAL STUDIES HAVE DEMONSTRATED BENEFIT FROM YOGA IN SPECIFIC PSYCHIATRIC SYMPTOMS AND A GENERAL SENSE OF WELL-BEING. OBJECTIVE: TO SYSTEMATICALLY EXAMINE THE EVIDENCE FOR EFFICACY OF YOGA IN THE TREATMENT OF SELECTED MAJOR PSYCHIATRIC DISORDERS. METHODS: ELECTRONIC SEARCHES OF THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS AND THE STANDARD BIBLIOGRAPHIC DATABASES, MEDLINE, EMBASE, AND PSYCINFO, WERE PERFORMED THROUGH APRIL 2011 AND AN UPDATED IN JUNE 2011 USING THE KEYWORDS YOGA AND PSYCHIATRY OR DEPRESSION OR ANXIETY OR SCHIZOPHRENIA OR COGNITION OR MEMORY OR ATTENTION AND RANDOMIZED CONTROLLED TRIAL (RCT). STUDIES WITH YOGA AS THE INDEPENDENT VARIABLE AND ONE OF THE ABOVE MENTIONED TERMS AS THE DEPENDENT VARIABLE WERE INCLUDED AND EXCLUSION CRITERIA WERE APPLIED. RESULTS: THE SEARCH YIELDED A TOTAL OF 124 TRIALS, OF WHICH 16 MET RIGOROUS CRITERIA FOR THE FINAL REVIEW. GRADE B EVIDENCE SUPPORTING A POTENTIAL ACUTE BENEFIT FOR YOGA EXISTS IN DEPRESSION (FOUR RCTS), AS AN ADJUNCT TO PHARMACOTHERAPY IN SCHIZOPHRENIA (THREE RCTS), IN CHILDREN WITH ADHD (TWO RCTS), AND GRADE C EVIDENCE IN SLEEP COMPLAINTS (THREE RCTS). RCTS IN COGNITIVE DISORDERS AND EATING DISORDERS YIELDED CONFLICTING RESULTS. NO STUDIES LOOKED AT PRIMARY PREVENTION, RELAPSE PREVENTION, OR COMPARATIVE EFFECTIVENESS VERSUS PHARMACOTHERAPY. CONCLUSION: THERE IS EMERGING EVIDENCE FROM RANDOMIZED TRIALS TO SUPPORT POPULAR BELIEFS ABOUT YOGA FOR DEPRESSION, SLEEP DISORDERS, AND AS AN AUGMENTATION THERAPY. LIMITATIONS OF LITERATURE INCLUDE INABILITY TO DO DOUBLE-BLIND STUDIES, MULTIPLICITY OF COMPARISONS WITHIN SMALL STUDIES, AND LACK OF REPLICATION. BIOMARKER AND NEUROIMAGING STUDIES, THOSE COMPARING YOGA WITH STANDARD PHARMACO- AND PSYCHOTHERAPIES, AND STUDIES OF LONG-TERM EFFICACY ARE NEEDED TO FULLY TRANSLATE THE PROMISE OF YOGA FOR ENHANCING MENTAL HEALTH. 2012 7 842 62 EFFECT OF YOGA ON PSYCHOLOGICAL DISTRESS AMONG WOMEN RECEIVING TREATMENT FOR INFERTILITY. BACKGROUND: INFERTILITY AMONG WOMEN HAS BEEN ASSOCIATED WITH SIGNIFICANT PSYCHOLOGICAL DISTRESS, ANXIETY, AND DEPRESSION. YOGA THERAPY HAS BEEN FOUND TO BE USEFUL IN THE MANAGEMENT OF ANXIETY, DEPRESSION AND PSYCHOLOGICAL DISTRESS. AIM: TO REVIEW STUDIES ON THE EFFECTIVENESS OF YOGA IN REDUCING PSYCHOLOGICAL DISTRESS AND IMPROVING CLINICAL OUTCOMES AMONG WOMEN RECEIVING TREATMENT FOR INFERTILITY. METHODOLOGY: PUBMED, SCIENCEDIRECT, AND GOOGLE SCHOLAR DATABASES WERE SEARCHED FOR STUDIES USING THE FOLLOWING INCLUSION CRITERIA: STUDIES PUBLISHED IN ENGLISH, THOSE PUBLISHED BETWEEN 2000 AND 2018, PUBLISHED IN PEER-REVIEWED JOURNALS, AND THOSE WITH YOGA AS AN INTERVENTION. REVIEW ARTICLES, STUDIES WITHOUT ANY YOGA INTERVENTIONS FOR INFERTILITY, AND MALE INFERTILITY WERE EXCLUDED. THE KEYWORDS INCLUDED FOR THE LITERATURE SEARCH WERE: YOGA, MINDFULNESS, RELAXATION TECHNIQUE, STRESS, DISTRESS, ANXIETY, INFERTILITY, IN VITRO FERTILIZATION (IVF), AND ASSISTED REPRODUCTIVE TECHNOLOGY (ART). RESULTS: THREE STUDIES SATISFIED THE SELECTION CRITERIA. TWO STUDIES INVOLVED HATHA YOGA INTERVENTION AND ONE STUDY USED STRUCTURED YOGA PROGRAM. THE VARIABLES ASSESSED IN THESE STUDIES WERE: (1) ANXIETY, (2) DEPRESSION, (3) EMOTIONAL DISTRESS, AND (4) FERTILITY-RELATED QUALITY OF LIFE. ALL THE STUDIES REPORTED AN IMPROVEMENT IN THE ANXIETY SCORES AFTER YOGA INTERVENTION. CONCLUSION: YOGA THERAPY MAY BE POTENTIALLY USEFUL IN IMPROVING ANXIETY SCORES AMONG WOMEN SUFFERING FROM INFERTILITY. MORE STUDIES ARE NEEDED IN THIS AREA TO ESTABLISH ROLE OF YOGA AS AN ADJUVANT DURING THE TREATMENT OF INFERTILITY. 2020 8 2482 48 YOGA AS AN ALTERNATIVE AND COMPLIMENTARY THERAPY FOR CARDIOVASCULAR DISEASE: A SYSTEMATIC REVIEW. CARDIOVASCULAR DISEASE IS A LEADING CAUSE OF DISABILITY AND DEATH WORLDWIDE. YOGA, A MIND-BODY EXERCISE, UTILIZES BREATHING TECHNIQUES WITH LOW-IMPACT PHYSICAL ACTIVITY THAT MAY BE AN ALTERNATIVE TREATMENT FOR CARDIOVASCULAR DISEASE. THE PURPOSE OF THIS SYSTEMATIC REVIEW WAS TO EXAMINE YOGA INTERVENTIONS FOR PATIENTS AT-RISK FOR AND/OR SUFFERING FROM CARDIOVASCULAR DISEASE. THE INCLUSION CRITERIA FOR INTERVENTIONS WERE ( A) PUBLISHED IN THE ENGLISH LANGUAGE BETWEEN 2005 AND 2015; ( B) INDEXED IN MEDLINE/PUBMED, CINAHL, OR ALT HEALTHWATCH; ( C) EMPLOYED A QUANTITATIVE DESIGN; AND ( D) APPLIED A YOGA INTERVENTION. TWELVE INTERVENTIONS MET THE INCLUSION CRITERIA, OF WHICH, ALL DOCUMENTED SIGNIFICANT IMPROVEMENTS IN ONE OR MORE FACTORS ASSOCIATED WITH CARDIOVASCULAR DISEASE. LIMITATIONS TO THE STUDIES IN THIS REVIEW INCLUDED A LACK OF STUDIES ADHERING TO THE INCLUSION CRITERIA, SMALL SAMPLE SIZES, AND HIGH ATTRITION RATES. DESPITE THE LIMITATIONS, THIS REVIEW DEMONSTRATES THE CLEAR POTENTIAL YOGA HAS AS AN ALTERNATIVE AND COMPLEMENTARY MEANS TO IMPROVE CARDIOVASCULAR DISEASE RISK. 2017 9 745 45 EFFECT OF SAHAJ YOGA ON DEPRESSIVE DISORDERS. SAHAJ YOGA IS A MEDITATIVE TECHNIQUE THAT HAS BEEN FOUND TO HAVE BENEFICIAL EFFECTS IN SOME PSYCHO-SOMATIC ILLNESSES. THE STUDY WAS CARRIED OUT ON 30 CASES (19 MALES, 11 FEMALES, AGE 18-45 YEARS) OF MAJOR DEPRESSION DIAGNOSED ON THE BASIS OF DSM IV CRITERIA. THE PATIENTS WERE THEN RANDOMLY DIVIDED INTO TWO GROUPS: GROUP 1: (10 MALES & 5 FEMALES) PATIENTS WHO WERE PRACTISING SAHAJ YOGA AND ALSO RECEIVED CONVENTIONAL ANTI-DEPRESSANTS. GROUP 2: (9 MALES & 6 FEMALES) PATIENTS WHO WERE ONLY RECEIVING CONVENTIONAL ANTI-DEPRESSANTS. TRAINING IN SAHAJ YOGA WAS CONDUCTED UNDER THE SUPERVISION OF A TRAINED SAHAJ YOGI FOR 8 WEEKS. AT START OF THE STUDY, ALL THE PATIENTS WERE SUBJECTED TO HAMILTON RATING SCALE FOR DEPRESSION (HAM-D) AND HAMILTON RATING SCALE FOR ANXIETY (HAM-A). ABOVE SCALES WERE AGAIN ASSESSED AFTER TWO MONTHS OF TREATMENT. THERE WAS SIGNIFICANT IMPROVEMENT IN HAM-D AS WELL AS HAM-A SCORES IN BOTH GROUP 1 AND GROUP 2 PATIENTS (P<0.001). HOWEVER, PERCENTAGE IMPROVEMENT IN HAM-D SCORES AND HAM-A SCORES IN PATIENTS RECEIVING SAHAJ YOGA WAS SIGNIFICANTLY HIGHER THAN IN GROUP 2 PATIENTS. THE NUMBER OF PATIENTS WHO WENT INTO REMISSION AFTER TWO MONTHS OF INTERVENTION WERE ALSO SIGNIFICANTLY HIGHER IN GROUP 1 PATIENTS (P=0.02). THE PRESENT STUDY DEMONSTRATES THAT SAHAJ YOGA HAS GOT A POTENTIAL ROLE AS A COMPONENT IN THE MANAGEMENT OF DEPRESSIVE DISORDERS. 2005 10 2023 57 SYSTEMATIC REVIEW OF YOGA FOR SYMPTOM MANAGEMENT DURING CONVENTIONAL TREATMENT OF BREAST CANCER PATIENTS. INTRODUCTION: BREAST CANCER IS ONE OF THE MOST COMMONLY DIAGNOSED CANCERS IN WOMEN IN THE US, AND ITS TREATMENTS HAVE SIGNIFICANT PHYSICAL AND PSYCHOLOGICAL SIDE EFFECTS AND LONG-TERM COMPLICATIONS CAUSING SIGNIFICANT MORBIDITY AND DECREASED QUALITY OF LIFE. INTEGRATIVE MEDICINE MODALITIES, SUCH AS YOGA, HAVE BEEN FOUND TO REDUCE SIDE EFFECTS OF CONVENTIONAL TREATMENTS WITHOUT INTERFERING WITH THE TREATMENT ITSELF AND IMPROVE QUALITY OF LIFE. IN THIS SYSTEMATIC REVIEW, WE SPECIFICALLY EXPLORED YOGA AS A POTENTIAL OPTION FOR SYMPTOMATIC MANAGEMENT IN PATIENTS UNDERGOING CONVENTIONAL BREAST CANCER TREATMENTS. METHODS: WE PERFORMED A LITERATURE SEARCH THAT WAS CONDUCTED TO INCLUDE THE DATABASES PUBMED, PSYCHINFO, COCHRANE LIBRARY, SCOPUS, AND CINAHL, RESULTING IN 28 RANDOMIZED CONTROLLED TRIAL (RCT) ARTICLES. WE REVIEW THE RESULTS OF THESE TRIALS REGARDING THE IMPACT OF YOGA IN THIS PATIENT POPULATION. RESULTS: OVERALL, THE MAJORITY OF THE RCT ARTICLES SHOWED SIGNIFICANT BENEFITS OF YOGA INTERVENTION IN VARIOUS ASPECTS OF QUALITY OF LIFE, FATIGUE, NAUSEA/VOMITING, SLEEP QUALITY, ANXIETY, DEPRESSION, AND DISTRESS. THERE ARE SEVERAL STUDIES THAT HAVE EXPLORED THE PHYSIOLOGICAL MECHANISM BEHIND THE EFFECTS OF YOGA AND FOUND THAT YOGA AFFECTS BOTH THE IMMUNE RESPONSE AND INFLAMMATION. DISCUSSION: THESE STUDIES REVEALED THAT YOGA HAS A POTENTIAL THERAPEUTIC ROLE IN THE SYMPTOMATIC MANAGEMENT OF BREAST CANCER PATIENTS, ENHANCING QUALITY OF LIFE DURING TREATMENT AS WELL AS IMPROVING ADHERENCE TO TREATMENT. FUTURE STUDIES WITH MORE DEFINED AND CONSISTENT METHODOLOGIES ARE NECESSARY TO FULLY UNDERSTAND THE POTENTIAL USE OF YOGA THERAPY IN PATIENTS WITH BREAST CANCER. 2022 11 2014 48 SUDARSHAN KRIYA YOGA: BREATHING FOR HEALTH. BREATHING TECHNIQUES ARE REGULARLY RECOMMENDED FOR RELAXATION, STRESS MANAGEMENT, CONTROL OF PSYCHOPHYSIOLOGICAL STATES, AND TO IMPROVE ORGAN FUNCTION. YOGIC BREATHING, DEFINED AS A MANIPULATION OF BREATH MOVEMENT, HAS BEEN SHOWN TO POSITIVELY AFFECT IMMUNE FUNCTION, AUTONOMIC NERVOUS SYSTEM IMBALANCES, AND PSYCHOLOGICAL OR STRESS-RELATED DISORDERS. THE AIM OF THIS STUDY WAS TO ASSESS AND PROVIDE A COMPREHENSIVE REVIEW OF THE PHYSIOLOGICAL MECHANISMS, THE MIND-BODY CONNECTION, AND THE BENEFITS OF SUDARSHAN KRIYA YOGA (SKY) IN A WIDE RANGE OF CLINICAL CONDITIONS. VARIOUS ONLINE DATABASES SEARCHED WERE MEDLINE, PSYCHINFO, EMBASE, AND GOOGLE SCHOLAR. ALL THE RESULTS WERE CAREFULLY SCREENED AND ARTICLES ON SKY WERE SELECTED. THE REFERENCES FROM THESE ARTICLES WERE CHECKED TO FIND ANY OTHER POTENTIALLY RELEVANT ARTICLES. SKY, A UNIQUE YOGIC BREATHING PRACTICE, INVOLVES SEVERAL TYPES OF CYCLICAL BREATHING PATTERNS, RANGING FROM SLOW AND CALMING TO RAPID AND STIMULATING. THERE IS MOUNTING EVIDENCE TO SUGGEST THAT SKY CAN BE A BENEFICIAL, LOW-RISK, LOW-COST ADJUNCT TO THE TREATMENT OF STRESS, ANXIETY, POST-TRAUMATIC STRESS DISORDER, DEPRESSION, STRESS-RELATED MEDICAL ILLNESSES, SUBSTANCE ABUSE, AND REHABILITATION OF CRIMINAL OFFENDERS. 2013 12 2783 36 YOGA THERAPY AS AN ADJUNCT TO CONVENTIONAL MANAGEMENT OF SYSTEMIC SCLEROSIS: A CASE SERIES. SYSTEMIC SCLEROSIS (SSC) IS AN AUTOIMMUNE DISORDER LEADING TO SIGNIFICANT DISABILITY AND LOSS OF QUALITY OF LIFE (QOL). YOGA HAS BECOME POPULAR IN RECENT TIMES FOR ITS POTENTIAL THERAPEUTIC BENEFITS. SINCE THERE ARE NO SCIENTIFIC REPORTS ON THE USE OF YOGA FOR SSC, WE PRESENT TWO FEMALE CASES (AGED 49 AND 29 RESPECTIVELY) OF LIMITED SSC (DURATION OF ILLNESS 4 AND 3 YEARS RESPECTIVELY) WHO UNDERWENT YOGA THERAPY AS AN ADJUNCT TO CONVENTIONAL MANAGEMENT IN A RESIDENTIAL SETTING FOR A PERIOD OF FIVE AND FOUR WEEKS, RESPECTIVELY. DURING THEIR STAY, THEY UNDERWENT A SPECIFICALLY DESIGNED YOGA MODULE. AFTER THEIR DISCHARGE, THEY WERE FOLLOWED-UP FOR FOUR WEEKS, DURING WHICH THEY WERE ASKED TO CONTINUE PRACTICING YOGA FOR 1 H EVERY DAY. BOTH OF THEM REPORTED A REDUCTION IN PAIN, STIFFNESS, SYMPTOM SCORES, AND IMPROVED QOL ON DISCHARGE AND AT THE FOLLOW-UP COMPARED TO THE VALUES ON ADMISSION. ERYTHROCYTE SEDIMENTATION RATE (ESR) AND C-REACTIVE PROTEIN (CRP), AS BIOMARKERS OF INFLAMMATION, REDUCED ON THE DISCHARGE WHEN COMPARED TO THE BASELINE. NO ADVERSE EVENTS WERE NOTED DURING THE STAY AND THE FOLLOW-UP. THUS, THE PRESENT CASE SERIES INDICATE A POSSIBLE BENEFICIAL ROLE OF YOGA AS AN ADJUNCT THERAPY TO CONVENTIONAL MANAGEMENT OF SSC. FURTHER STUDIES IN THE AREA ARE WARRANTED TO ASCERTAIN THE EFFICACY OF YOGA FOR SSC. 2021 13 91 58 A MULTICOMPONENT YOGA-BASED, BREATH INTERVENTION PROGRAM AS AN ADJUNCTIVE TREATMENT IN PATIENTS SUFFERING FROM GENERALIZED ANXIETY DISORDER WITH OR WITHOUT COMORBIDITIES. OBJECTIVES: THE AIM OF THIS STUDY IS TO EVALUATE THE EFFICACY AND TOLERABILITY OF SUDARSHAN KRIYA YOGA (SKY) COURSE IN GENERALIZED ANXIETY DISORDER (GAD) OUTPATIENTS, WHO AFTER EIGHT WEEKS OF AN APPROPRIATE DOSE OF TRADITIONAL THERAPY HAD NOT YET ACHIEVED REMISSION. SUBJECTS: THE ADULT PARTICIPANTS (18-65 YEARS) WERE OUTPATIENTS WITH A PRIMARY DIAGNOSIS OF GAD WITH OR WITHOUT COMORBIDITIES ON THE MINI-INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW (MINI). PARTICIPANTS HAD A MINIMUM OF EIGHT WEEKS STANDARD TREATMENT WITH AN APPROPRIATE DOSE OF A STANDARD PRESCRIPTION ANXIOLYTIC, A CLINICIAN GLOBAL IMPRESSION-SEVERITY (CGI-S) SCORE OF 5-7, A HAMILTON ANXIETY SCALE (HAM-A) TOTAL SCORE >/=20 INCLUDING A SCORE OF >2 ON THE ANXIOUS MOOD AND TENSION ITEMS. MATERIALS AND METHODS: FORTY-ONE PATIENTS WERE ENROLLED IN AN OPEN-LABEL TRIAL OF THE SKY COURSE AS AN ADJUNCT TO STANDARD TREATMENT OF GAD AT THE START CLINIC FOR MOOD AND ANXIETY DISORDERS, A TERTIARY CARE MOOD AND ANXIETY DISORDER CLINIC IN TORONTO. THE SKY COURSE WAS ADMINISTERED OVER FIVE DAYS (22 H TOTAL). SUBJECTS WERE ENCOURAGED TO PRACTICE THE YOGA BREATHING TECHNIQUES AT HOME FOR 20 MIN PER DAY AFTER THE COURSE AND WERE OFFERED GROUP PRACTICE SESSIONS FOR 2 H ONCE A WEEK LED BY CERTIFIED YOGA INSTRUCTORS. THE PRIMARY OUTCOME MEASURE WAS THE MEAN CHANGE FROM PRE-TREATMENT ON THE HAM-A SCALE. PSYCHOLOGICAL MEASURES WERE OBTAINED AT BASELINE AND FOUR WEEKS AFTER COMPLETING THE INTERVENTION. RESULTS: THIRTY-ONE PATIENTS COMPLETED THE PROGRAM (MEAN AGE 42.6 +/- 13.3 YEARS). AMONG COMPLETERS, SIGNIFICANT REDUCTIONS OCCURRED IN THE PRE- AND POST-INTERVENTION MEAN HAM-A TOTAL SCORE (T=4.59; P<0.01) AND PSYCHIC SUBSCALE (T=5.00; P